COMMUNIQUÉS West-GlobeNewswire

Marrone Bio Innovations and DISAGRO Sign Exclusive Distribution Agreement for REGALIA® Maxx Biofungicide in Central America
20/12/2017
DAVIS, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and [...]
Avinger Receives CE Marking Approval for Next Generation Pantheris Image-Guided Atherectomy Device
20/12/2017
REDWOOD CITY, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced Conformité Européenne (CE) Marking [...]
Skyline Medical and Helomics expand into Next Generation Sequencing for Personalized Medicine
20/12/2017
MINNEAPOLIS, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ: SKLN ) (“Skyline” or the “Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, [...]
PolarityTE™ Announces a New 200,000 sq ft Polarity Campus and Corporate Headquarters to Meet the Demand for SkinTE™ and Accelerate Core Technology Platforms into 2018
20/12/2017
SALT LAKE CITY, Dec. 20, 2017 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (NASDAQ: COOL ) today officially announced that the company has continued to expand its R&D and biomedical manufacturing capabilities and moved its [...]
Indi Molecular Appoints Stephen Worsley Senior VP Business Development
20/12/2017
CULVER CITY, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Indi Molecular , an emerging life sciences company, announced today that it has appointed Stephen Worsley as senior vice president business development. Worsley is [...]
Vystar Names Furniture Industry Leader Steve Rotman as CEO; Appoints 3 Board Members
20/12/2017
ATLANTA and WORCESTER, Mass., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Vystar Corporation (OCT Pink:VYST) today announced the appointment of Steven Rotman as its Chief Executive Officer and member of the Board of Directors, [...]
Clearside Biomedical, Inc. to Present at the 36th Annual J.P. Morgan Healthcare Conference
20/12/2017
ALPHARETTA, Ga., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ: CLSD ), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat back-of-the-eye diseases, [...]
Eloxx Pharmaceuticals Completes Acquisition Transaction with Sevion Therapeutics
20/12/2017
WALTHAM, Mass. and REHOVOT, Israel and SAN DIEGO, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals Ltd. (“Eloxx”) and Sevion Therapeutics, Inc. (OTCQB:SVON) (“Sevion”) today announced the two companies have [...]
Aduro Biotech Expands Leading Intellectual Property Position in STING Field with Newly Issued Patent
20/12/2017
BERKELEY, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq: ADRO ), a biopharmaceutical company with three distinct immunotherapy technologies, today announced that the United States Patent and [...]
Precipio Launches Its Second New ICE-COLD PCR™ Targeted Enrichment Kit To Identify Mutations in Lung Cancer Using Liquid (Blood) Biopsies On Sanger Sequencing Platforms
20/12/2017
NEW HAVEN, Conn., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO ), announced today the launch of the second new version of its ICE-COLD PCR™ (ICP) enrichment kit, used to identify resistance mutations [...]
HTG Molecular Diagnostics to Participate in Corporate Access Event in San Francisco, January 8 – 10, 2018
20/12/2017
TUCSON, Ariz., Dec. 20, 2017 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (NASDAQ: HTGM ), a provider of instruments, reagents and services for molecular profiling applications, today announced that its senior [...]
R1 RCM to Present at the 36th Annual J.P. Morgan Healthcare Conference
20/12/2017
CHICAGO, Dec. 20, 2017 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM ), a leading provider of revenue cycle management services to healthcare providers, today announced its management team will present at the 36 th [...]
New Patent Issued to AMAG Pharmaceuticals Entitled "Methods of Reducing Risk of Preterm Birth"
20/12/2017
WALTHAM, Mass., Dec. 20, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced the issuance of U.S. Patent Number 9,844,558 entitled “Methods of Reducing Risk of Preterm Birth.” This newly [...]
Opiant Pharmaceuticals Announces Significant Financial Developments Related to NARCAN® Nasal Spray for Opioid Overdose
20/12/2017
Opiant Expects to Receive 90% of NARCAN Sales-Related Royalty and Milestone Payments, Going Forward SANTA MONICA, Calif., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT ), a [...]
Ovid Therapeutics Announces TAK-935/OV935 Granted Orphan Drug Designation by U.S. FDA for Treatment of Lennox-Gastaut Syndrome
20/12/2017
NEW YORK, Dec. 20, 2017 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID ), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]
Green Cures & Botanical Distribution, Inc. Appoints New CEO, Mr. William Pitsicalis
20/12/2017
LOS ANGELES, CA , Dec. 20, 2017 (GLOBE NEWSWIRE) -- Green Cures and Botanical Distribution Inc. (OTC PINK: GRCU), an innovative hemp-infused nutrition, botanical, sports, and body care products company, has appointed Mr [...]
IBEX Grants Stock Options and Amends Incentive Stock Option Plan
20/12/2017
MONTREAL, Dec. 20, 2017 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX-V: IBT ) announces that on December 19, 2017, its Board of Directors granted an aggregate of 675,000 stock options to [...]
AzurRx BioPharma Announces Publication of U.S. Patent Application for AZX1101
20/12/2017
BROOKLYN, N.Y., Dec. 20, 2017 (GLOBE NEWSWIRE) -- AzurRx BioPharma Inc.(NASDAQ: AZRX ) (“AzurRx” or the “Company”), today announced that the United States Patent and Trademark Office has published patent application [...]
New Member appointed to the Board of Directors of Neuralstem
20/12/2017
GERMANTOWN, Md., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq: CUR ), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that Xi Chen, Ph.D., has been [...]

Pages